Stability evaluation and sensitive determination of antiviral drug, valacyclovir and its metabolite acyclovir in human plasma by a rapid liquid chromatography–tandem mass spectrometry method-Reference-Cited by-同舟云学术

Stability evaluation and sensitive determination of antiviral drug, valacyclovir and its metabolite acyclovir in human plasma by a rapid liquid chromatography–tandem mass spectrometry method

Published:2009-03 Issue:8-9 Volume:877 Page:680-688
ISSN:1570-0232
Container-title:Journal of Chromatography B
language:en
Short-container-title:Journal of Chromatography B

Author:

Yadav Manish,Upadhyay Vivek,Singhal Puran,Goswami Sailendra,Shrivastav Pranav S.

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry

Reference38 articles.

1. Valacyclovir therapy to reduce recurrent genital herpes in pregnant women

2. Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy

3. Separation methods for acyclovir and related antiviral compounds

4. Gene Expression in the Human Intestine and Correlation with Oral Valacyclovir Pharmacokinetic Parameters

5. Acyclovir prodrug for the intestinal di/tri-peptide transporter PEPT1: comparison of in vivo bioavailability in rats and transport in Caco-2 cells

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carbon Nano-Dots based potentiometric sensor for the assay of the antiviral agent; Valacyclovir: In-Depth DFT Calculations, application to the pharmaceutical formulation and greenness assessment;Microchemical Journal;2024-11

2. Design and fabrication of machine learning trained silver nanoparticles-infused multi-walled carbon nanotube-based sensor for antiviral drug monitoring;Microchemical Journal;2024-08

3. Three-dimensional heterogeneous electro-Fenton system with reduced graphene oxide based particle electrode for Acyclovir removal;Chinese Chemical Letters;2024-01

4. A decreasing plasma concentration of a toxicologically active metabolite 9-carboxymethoxymethylguanine after dialysis – A potential new clinical biomarker for improving encephalopathy in patients treated with acyclovir;Journal of Infection and Chemotherapy;2023-11

5. Serum and cerebrospinal fluid acyclovir pharmacokinetics in a neonate with HSV-2 meningoencephalitis;Journal of Infection and Chemotherapy;2022-08